TNNI3 and pulmonary arterial hypertension: Heresi and co-authors [14] aimed to examine whether a cardiac troponin I (cTnI) measurement, utilizing a sensitive assay, correlated with disease severity and prognosis in pulmonary arterial hypertension (PAH) patients.